| Dr Ricky L Ledkins, MD | |
|
2000 Pepperell Pkwy, Opelika, AL 36801-5452 | |
| (334) 528-1112 | |
| (334) 528-1547 |
| Full Name | Dr Ricky L Ledkins |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 33 Years |
| Location | 2000 Pepperell Pkwy, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154388783 | NPI | - | NPPES |
| 510-79264 | Other | AL | BLUE CROSS OF AL PROV # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 16622 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| East Alabama Medical Center And Snf | Opelika, AL | Hospital |
| Bullock County Hospital | Union springs, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The East Alabama Health Care Authority | 3072403237 | 81 |
News Archive
Swedish Neuroscience Institute (SNI) will open its new MS Center at Swedish to patients on April 9. Carefully designed for easy accessibility and to promote the well-being of people with Multiple Sclerosis (MS), the new 11,700-square-foot center gives SNI the ability to consolidate all of its MS services into one facility.
Women under 40 are hit hardest by the escalating incidence of melanoma, according to a Mayo Clinic study published in the April issue of Mayo Clinic Proceedings, out today. Researchers examined records from a decades-long database of all patient care in Olmsted County, Minn., and looked for first-time diagnoses of melanoma in patients 18-39 from 1970 to 2009. Melanoma cases increased eightfold among women in that time and fourfold for men, the authors say. However, death rates from melanoma fell during the same period, suggesting that early interventions may be helping to save some lives, said the researchers.
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
British scientists are well on the way to developing a new drug to fight the 'superbug' Methicillin-resistant Staphylococcus aureus (MRSA).
Oxygen Biotherapeutics, Inc. has announced that enrollment for the company's first dermatological study will begin later this month at St. John's Medical College Hospital in Bangalore, India. The company received formal approval from the hospital's Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.
› Verified 4 days ago
| Entity Name | Professional Resources Management, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992812382 PECOS PAC ID: 5597748350 Enrollment ID: O20040611000549 |
News Archive
Swedish Neuroscience Institute (SNI) will open its new MS Center at Swedish to patients on April 9. Carefully designed for easy accessibility and to promote the well-being of people with Multiple Sclerosis (MS), the new 11,700-square-foot center gives SNI the ability to consolidate all of its MS services into one facility.
Women under 40 are hit hardest by the escalating incidence of melanoma, according to a Mayo Clinic study published in the April issue of Mayo Clinic Proceedings, out today. Researchers examined records from a decades-long database of all patient care in Olmsted County, Minn., and looked for first-time diagnoses of melanoma in patients 18-39 from 1970 to 2009. Melanoma cases increased eightfold among women in that time and fourfold for men, the authors say. However, death rates from melanoma fell during the same period, suggesting that early interventions may be helping to save some lives, said the researchers.
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
British scientists are well on the way to developing a new drug to fight the 'superbug' Methicillin-resistant Staphylococcus aureus (MRSA).
Oxygen Biotherapeutics, Inc. has announced that enrollment for the company's first dermatological study will begin later this month at St. John's Medical College Hospital in Bangalore, India. The company received formal approval from the hospital's Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.
› Verified 4 days ago
| Entity Name | The East Alabama Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073685483 PECOS PAC ID: 3072403237 Enrollment ID: O20040824001092 |
News Archive
Swedish Neuroscience Institute (SNI) will open its new MS Center at Swedish to patients on April 9. Carefully designed for easy accessibility and to promote the well-being of people with Multiple Sclerosis (MS), the new 11,700-square-foot center gives SNI the ability to consolidate all of its MS services into one facility.
Women under 40 are hit hardest by the escalating incidence of melanoma, according to a Mayo Clinic study published in the April issue of Mayo Clinic Proceedings, out today. Researchers examined records from a decades-long database of all patient care in Olmsted County, Minn., and looked for first-time diagnoses of melanoma in patients 18-39 from 1970 to 2009. Melanoma cases increased eightfold among women in that time and fourfold for men, the authors say. However, death rates from melanoma fell during the same period, suggesting that early interventions may be helping to save some lives, said the researchers.
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
British scientists are well on the way to developing a new drug to fight the 'superbug' Methicillin-resistant Staphylococcus aureus (MRSA).
Oxygen Biotherapeutics, Inc. has announced that enrollment for the company's first dermatological study will begin later this month at St. John's Medical College Hospital in Bangalore, India. The company received formal approval from the hospital's Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ricky L Ledkins, MD Po Box 4283, Opelika, AL 36803-4283 Ph: (334) 528-1112 | Dr Ricky L Ledkins, MD 2000 Pepperell Pkwy, Opelika, AL 36801-5452 Ph: (334) 528-1112 |
News Archive
Swedish Neuroscience Institute (SNI) will open its new MS Center at Swedish to patients on April 9. Carefully designed for easy accessibility and to promote the well-being of people with Multiple Sclerosis (MS), the new 11,700-square-foot center gives SNI the ability to consolidate all of its MS services into one facility.
Women under 40 are hit hardest by the escalating incidence of melanoma, according to a Mayo Clinic study published in the April issue of Mayo Clinic Proceedings, out today. Researchers examined records from a decades-long database of all patient care in Olmsted County, Minn., and looked for first-time diagnoses of melanoma in patients 18-39 from 1970 to 2009. Melanoma cases increased eightfold among women in that time and fourfold for men, the authors say. However, death rates from melanoma fell during the same period, suggesting that early interventions may be helping to save some lives, said the researchers.
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
British scientists are well on the way to developing a new drug to fight the 'superbug' Methicillin-resistant Staphylococcus aureus (MRSA).
Oxygen Biotherapeutics, Inc. has announced that enrollment for the company's first dermatological study will begin later this month at St. John's Medical College Hospital in Bangalore, India. The company received formal approval from the hospital's Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.
› Verified 4 days ago
Dr. Michael Nicholas Barbaree, D.O Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-2161 | |
Chima Austin Ukachi, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3320 Skyway Dr Ste 807, Opelika, AL 36801 Phone: 334-539-1770 | |
Dr. Kim J Williams, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-1547 | |
Zachary Smith, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-4339 | |
Dr. Alan L Moore, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-1547 | |
Dr. James D Crosby, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-1547 |